反应详情

To a stirring solution of 460 mg (0.80 mmol) of 2-[3-(Benzyloxymethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-benzo[b][1,4]diazepin-1-yl]-N-isopropyl-N-(4-methoxy-phenyl)-acetamide in 10 mL of DMF/CHCl3 1/1 is added 200 mg of 10% Pd/C. The resulting mixture is stirred at RT over an atmosphere of H2 gas (balloon) for 6 h. The reaction mixture is filtered through a pad of Celite to remove the catalyst, rinsing with EtOAc. The filtrate is diluted further with 20 mL of EtOAc and extracted with H2O (2×40 mL). The organic layer is separated, dried (MgSO4), and the solvents removed in vacuo. Purification by trituration with EtOAc/Et2O 1/1 afforded 365 mg of the title compound as a white solid: mp 136°-139° C.; 1H NMR (CDCl3, 400 MHz) δ7.40-7.19 (m, 8H), 7.10 (m, 2H), 6.94 (m, 3H), 4.99 (m, 1H), 4.28 (m, 2H), 4.15 (m, 2H), 3.84 (s, 3H), 3.65 (t, 1H, J=6.9), 2.37 (t, 1H, J=7.3), 1.06 (2×d, 6H, J=6.3); low resolution MS (FAB)m/e 488 (MH+), 323, 277; Anal. (C28H29N3O5) Calcd. C, 68.98; H, 6.00; N, 8.62 Found C, 67.05; H, 5.99; N, 8.33.

1. filtrationThe reaction mixture is filtered through a pad of Celite
2. customto remove the catalyst
3. washrinsing with EtOAc
4. additionThe filtrate is diluted further with 20 mL of EtOAc
5. extractionextracted with H2O (2×40 mL)
6. customThe organic layer is separated
7. dry with materialdried (MgSO4)
8. customthe solvents removed in vacuo
9. customPurification by trituration with EtOAc/Et2O 1/1